Security
Rafael Holdings, Inc. Warrant · RFL.WS
RFL.WSNYSEWarrantHistorical · closed Dec 11, 2025CIK 1713863Updated Nov 10, 2026
Current security for this SEC filerRFL · NYSE
RFL.WS price & chart
Historical security
This listing closed Dec 11, 2025. Live provider charts are shown only for current listings.
Current security: RFL
About the company
Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. Our lead candidate is remibetadex (Trappsol® Cyclo™), for which we have completed a pivotal Phase 3 study in Niemann-Pick Disease Type C (“NPC”) and submitted an NDA to the FDA in October 2026. NPC is a rare, fatal and progressive genetic disorder. We also hold interests in other clinical-stage and early-stage pharmaceutical development companies and an orthopedic-focused medical device company.
In the news
No coverage from other publishers is available.
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
10-K filing
Results of Operations and Financial Condition · Regulation FD Disclosure · Other Events
Items 2.02, 7.01, 8.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
4 filing
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 91,990,000Source | 108,096,000Source | 101,623,000Source | 99,315,000Source | 83,042,000Source | 106,149,000Source | 105,375,000Source | 87,835,000Source | 114,109,000Source | 96,832,000Source | 98,829,000Source | 118,320,000Source |
| Property, Plant and Equipment, NetUSD | 1,524,000Source | 1,614,000Source | 2,156,000Source | 1,545,000Source | 1,933,000Source | 2,064,000Source | 1,562,000Source | 2,078,000Source | 1,596,000Source | 2,120,000Source | 1,695,000Source | 1,770,000Source |
| GoodwillUSD | 19,939,000Source | 28,278,000Source | 3,571,000Source | 19,939,000Source | — | 3,571,000Source | 19,939,000Source | 3,050,000Source | 19,939,000Source | 3,050,000Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 896,000Source | 1,027,000Source | 1,851,000Source | 929,000Source | 1,787,000Source | 1,888,000Source | 962,000Source | 1,818,000Source | 994,000Source | 1,847,000Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 30,497,000Source | 37,936,000Source | 7,436,000Source | 37,779,000Source | 48,319,000Source | 7,136,000Source | 45,539,000Source | 8,159,000Source | 52,769,000Source | 2,675,000Source | 21,498,000Source | 26,537,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 294,000Source | 414,000Source | 443,000Source | 295,000Source | 200,000Source | 379,000Source | 413,000Source | 201,000Source | 627,000Source | 426,000Source | 213,000Source | 157,000Source |
| Inventory, NetUSD | 276,000Source | 288,000Source | — | 271,000Source | — | — | 272,000Source | — | 281,000Source | — | — | — |
| Assets, CurrentUSD | 34,858,000Source | 42,443,000Source | 73,806,000Source | 42,447,000Source | 65,833,000Source | 75,073,000Source | 48,321,000Source | 70,481,000Source | 56,714,000Source | 72,502,000Source | 82,941,000Source | 108,347,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 872,000Source | 837,000Source | 445,000Source | 873,000Source | 725,000Source | 487,000Source | 513,000Source | 2,942,000Source | 786,000Source | 430,000Source | 914,000Source | 4,621,000Source |
| Other Assets, NoncurrentUSD | 80,000Source | 41,000Source | 73,000Source | 28,000Source | 20,000Source | 42,000Source | 29,000Source | 27,000Source | 34,000Source | 35,000Source | 9,000Source | 1,387,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 11,187,000Source | 23,578,000Source | 11,064,000Source | 16,057,000Source | 10,479,000Source | 3,895,000Source | 16,195,000Source | 10,451,000Source | 15,738,000Source | 10,574,000Source | 2,200,000Source | 21,114,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | — | 9,400,000Source | — | — | — | — | — | — | — | — | — | 8,000Source |
| Additional Paid in CapitalUSD | — | — | — | — | — | — | — | — | — | — | — | 262,023,000Source |
| Retained Earnings (Accumulated Deficit)USD | -252,722,000Source | -220,169,000Source | -197,275,000Source | -248,496,000Source | -215,390,000Source | -164,924,000Source | -242,079,000Source | -210,749,000Source | -232,263,000Source | — | -167,333,000Source | -165,457,000Source |
| Stockholders' Equity Attributable to ParentUSD | 75,386,000Source | 80,578,000Source | 86,100,000Source | 79,169,000Source | 69,381,000Source | 104,939,000Source | 85,181,000Source | 73,516,000Source | 94,391,000Source | 82,185,000Source | 100,293,000Source | 100,515,000Source |
| Additional Paid in Capital, Common StockUSD | 323,234,000Source | 296,648,000Source | 279,636,000Source | 323,081,000Source | 280,831,000Source | 266,159,000Source | 322,730,000Source | 280,359,000Source | 322,161,000Source | — | 264,010,000Source | — |
| Liabilities and EquityUSD | 91,990,000Source | 108,096,000Source | 101,623,000Source | 99,315,000Source | 83,042,000Source | 106,149,000Source | 105,375,000Source | 87,835,000Source | 114,109,000Source | 96,832,000Source | 98,829,000Source | 118,320,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 11,020,000Source | 11,030,000Source | 7,541,000Source | 12,357,000Source | 7,110,000Source | 3,263,000Source | 12,076,000Source | 7,239,000Source | 11,600,000Source | 7,514,000Source | 2,145,000Source | 21,026,000Source |
| Accounts Payable, CurrentUSD | 7,043,000Source | 7,793,000Source | 2,571,000Source | 8,172,000Source | 2,546,000Source | 509,000Source | 6,794,000Source | 2,700,000Source | 6,893,000Source | 2,556,000Source | 333,000Source | 564,000Source |
| Deferred Income Tax Liabilities, NetUSD | 138,000Source | 9,002,000Source | 613,000Source | 138,000Source | — | 545,000Source | 138,000Source | — | 138,000Source | 73,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 27,000Source | 25,000Source | 13,000Source | 27,000Source | — | 87,000Source | 27,000Source | — | 27,000Source | 5,000Source | 55,000Source | 88,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 5,417,000Source | 3,940,000Source | 4,459,000Source | 4,089,000Source | 3,182,000Source | -2,685,000Source | 3,999,000Source | 3,868,000Source | 3,980,000Source | 4,073,000Source | -3,664,000Source | -3,309,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,764,000Source | 1,866,000Source | 1,745,000Source | 2,778,000Source | 1,412,000Source | 845,000Source | 3,860,000Source | 1,379,000Source | 3,304,000Source | 1,798,000Source | 763,000Source | 1,875,000Source |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | 624,000Source | 219,000Source | -38,000Source | 358,000Source | 135,000Source | -88,000Source | 358,000Source | 132,000Source | 358,000Source | 111,000Source | -353,000Source | -63,000Source |
| Deferred Tax Liabilities, NetUSD | — | 9,000,000Source | 545,000Source | — | — | 545,000Source | — | — | 138,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -2,898,000Source | -4,051,000Source | -6,327,000Source | -5,327,000Source | -9,797,000Source | -9,211,000Source | -30,643,000Source | -65,003,000Source | -2,215,000Source | -142,377,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 48,000Source | 62,000Source | 55,000Source | 90,000Source | 50,000Source | 86,000Source | 288,000Source | 225,000Source | 78,000Source | 72,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 598,000Source | 359,000Source | 2,123,000Source | 2,296,000Source | 2,188,000Source | -917,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -214,000Source | -225,000Source | 151,000Source | — | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -9,000Source | — | 11,000Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -165,000Source | -97,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,806,000Source | -3,042,000Source | -18,924,000Source | -7,802,000Source | -10,886,000Source | -26,079,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 2,709,000Source | -1,099,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -430,000Source | 8,575,000Source | 44,035,000Source | -10,820,000Source | 21,211,000Source | -63,796,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 6,000Source | 4,000Source | 143,000Source | — | — |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 28,000Source | 48,000Source | 215,000Source | — | — | 75,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -30,000Source | -48,000Source | 24,830,000Source | -179,000Source | -15,218,000Source | 103,864,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -7,230,000Source | 5,484,000Source | 50,094,000Source | -18,823,000Source | -5,039,000Source | 13,683,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 30,497,000Source | 37,936,000Source | 37,779,000Source | 48,319,000Source | 45,539,000Source | 8,159,000Source | 52,769,000Source | 2,675,000Source | 21,498,000Source | 26,537,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 36,000Source | -1,000Source | 153,000Source | -22,000Source | -146,000Source | -306,000Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | — | — | — | — | — | 472,000Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 172,000Source | 353,000Source | 387,000Source | 502,000Source | 598,000Source | 359,000Source | 2,123,000Source | 2,296,000Source | 2,188,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 472,000Source |
| Amortization of Intangible AssetsUSD | — | — | 32,000Source | 32,000Source | 33,000Source | 38,000Source | 32,000Source | 38,000Source | 142,000Source | 88,000Source | — | — |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | -45,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | — | — | — | -16,000Source | — | 194,000Source | 178,000Source | 1,772,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | — | — | 1,000Source |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | — | — | — | — | — | — | — | — | — | — | 6,784,000Source | -1,830,000Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | — | — | — | — | — | — | — | — | — | — | -306,000Source | — |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 334,000Source | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | 25,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | -53,000Source | -42,000Source | -5,000Source |
| Gain (Loss) on Disposition of Real Estate, Discontinued OperationsUSD | — | — | — | — | — | — | — | — | — | — | — | -501,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | -46,000Source | — | — |
| Gain (Loss) on Sale of PropertiesUSD | — | — | — | — | — | — | — | — | — | — | 1,195,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | 54,000Source | — | -81,000Source | 27,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 2,140,000Source | 3,170,000Source | 2,270,000Source | 2,591,000Source | 2,838,000Source | 2,523,000Source | 13,781,000Source | 8,854,000Source | 8,932,000Source | 17,270,000Source |
| GoodwillUSD | — | — | 19,939,000Source | 28,278,000Source | 19,939,000Source | — | 19,939,000Source | 3,050,000Source | 19,939,000Source | 3,050,000Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | 3,050,000Source | — | — | 3,050,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -9,211,000Source | — | -65,003,000Source | -8,693,000Source | -140,547,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -8,693,000Source | -140,547,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 6,478,000Source | -1,830,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | — | — | — | 1,830,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -575,000Source |
| Income Tax Expense (Benefit)USD | — | — | 6,000Source | -2,411,000Source | 48,000Source | 20,000Source | 10,000Source | 12,000Source | -2,553,000Source | -2,680,000Source | -255,000Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | 1,772,000Source | 154,000Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 33,000Source | -45,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,226,000Source | -4,779,000Source | -6,417,000Source | -4,641,000Source | -9,816,000Source | -9,006,000Source | -30,520,000Source | -34,410,000Source | -1,876,000Source | -140,547,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 1,328,000Source | 728,000Source | 90,000Source | -686,000Source | 19,000Source | -205,000Source | -123,000Source | -30,593,000Source | -339,000Source | -17,719,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | -9,006,000Source | — | -34,410,000Source | -1,876,000Source | -124,658,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Other Depreciation and AmortizationUSD | — | — | — | — | — | — | — | — | — | — | — | 1,317,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -25,000Source | 154,000Source | -1,000Source | -78,000Source | 115,000Source | -2,000Source | 310,000Source | — | — | — |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | 3,600,000Source | — | 3,600,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 25,001,000Source | — | — | 99,170,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | — | — | — | — | — | 28,500,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | -194,000Source | — | -46,000Source | 309,000Source | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | — | — | 1,191,000Source | — | 31,850,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | -1,393,000Source | — | 614,000Source | — | -4,365,000Source | — | — | 33,000Source | — |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | — | — | — | — | — |
| Gain (Loss) on Sale of Investments | — | — | — | — | — | — | — | — | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | —Source | — | — | — | — | — | — | — | — | — |
| InterestExpenseNonoperating | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 179,000Source | 362,000Source | 211,000Source | 77,000Source | 240,000Source | 128,000Source | 917,000Source | 637,000Source | 279,000Source | 410,000Source |
| Cost of Goods and Services Sold | — | — | — | — | — | —Source | — | —Source | — | —Source | — | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 16,978,000Source |
| Operating Income (Loss)USD | — | — | -6,870,000Source | -5,913,000Source | -6,655,000Source | -6,639,000Source | -10,141,000Source | -3,844,000Source | -29,159,000Source | -102,627,000Source | -15,043,000Source | -60,477,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -25,000Source | 154,000Source | -1,000Source | -78,000Source | 115,000Source | -2,000Source | 310,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,892,000Source | -6,462,000Source | -6,279,000Source | -5,307,000Source | -9,787,000Source | -9,199,000Source | -33,196,000Source | -67,261,000Source | -8,745,000Source | -139,972,000Source |
| Income Tax Expense (Benefit)USD | — | — | 6,000Source | -2,411,000Source | 48,000Source | 20,000Source | 10,000Source | 12,000Source | -2,553,000Source | -2,680,000Source | -255,000Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 1,328,000Source | 728,000Source | 90,000Source | -686,000Source | 19,000Source | -205,000Source | -123,000Source | -30,593,000Source | -339,000Source | -17,719,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,226,000Source | -4,779,000Source | -6,417,000Source | -4,641,000Source | -9,816,000Source | -9,006,000Source | -30,520,000Source | -34,410,000Source | -1,876,000Source | -140,547,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.08Source | -0.19Source | -0.13Source | -0.19Source | -0.19Source | -0.37Source | -1.04Source | -1.45Source | -0.08Source | -6.31Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.08Source | -0.19Source | -0.13Source | -0.19Source | -0.19Source | -0.37Source | -1.04Source | -1.45Source | -0.08Source | -6.31Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 51,229,576Source | 25,238,501Source | 51,226,095Source | 24,150,218Source | 51,184,407Source | 24,062,854Source | 29,422,221Source | 23,745,516Source | 23,263,211Source | 19,767,342Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 51,229,576Source | 25,238,501Source | 51,226,095Source | 24,150,218Source | 51,184,407Source | 24,062,854Source | 29,422,221Source | 23,745,516Source | 23,263,211Source | 19,767,342Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 32,000Source | 32,000Source | 33,000Source | 38,000Source | 32,000Source | 38,000Source | 142,000Source | 88,000Source | — | — |
| Business Combination, Acquisition Related CostsUSD | — | — | — | 200,000Source | — | 100,000Source | — | 100,000Source | 1,000,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -2,388,000Source | -2,583,000Source | -255,000Source | — |
| Debt Securities, Realized Gain (Loss)USD | — | — | — | — | — | -16,000Source | — | 194,000Source | 178,000Source | 1,772,000Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 48,000Source | 62,000Source | 55,000Source | 90,000Source | 50,000Source | 86,000Source | 288,000Source | 225,000Source | 78,000Source | 72,000Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | — | — | — | — | — | — | — | — | — | — | -306,000Source | — |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 334,000Source | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | 25,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | -53,000Source | -42,000Source | -5,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | -46,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 2,140,000Source | 3,170,000Source | 2,270,000Source | 2,591,000Source | 2,838,000Source | 2,523,000Source | 13,781,000Source | 8,854,000Source | 8,932,000Source | 17,270,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | 3,050,000Source | — | — | 3,050,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -9,211,000Source | — | -65,003,000Source | -8,693,000Source | -140,547,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -32,338,000Source | — | — | -122,828,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -8,693,000Source | -140,547,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | — | -1.45Source | -0.36Source | -6.22Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | — | -1.45Source | -0.36Source | -6.22Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 6,478,000Source | -1,830,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | — | — | — | 1,830,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -575,000Source |
| Interest ExpenseUSD | — | — | — | 165,000Source | — | 163,000Source | 160,000Source | 162,000Source | 658,000Source | 248,000Source | — | 6,000Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 1,200,000Source |
| Interest Income, OtherUSD | — | — | 286,000Source | 472,000Source | 337,000Source | 489,000Source | 399,000Source | 568,000Source | 1,996,000Source | 2,383,000Source | 3,253,000Source | 201,000Source |
| Lease IncomeUSD | — | — | 90,000Source | 77,000Source | 86,000Source | 77,000Source | 86,000Source | 77,000Source | 309,000Source | 282,000Source | — | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | 1,772,000Source | 154,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | -9,006,000Source | — | -34,410,000Source | -1,876,000Source | -124,658,000Source |
| Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD | — | — | — | — | — | — | — | — | — | -34,410,000Source | -8,354,000Source | — |
| Other General and Administrative ExpenseUSD | — | — | 150,000Source | 308,000Source | 343,000Source | 464,000Source | 170,000Source | 320,000Source | 1,962,000Source | 2,000,000Source | 3,044,000Source | — |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 157,000Source |
| Other IncomeUSD | — | — | — | — | — | — | — | — | — | 118,000Source | — | — |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | -194,000Source | — | -46,000Source | 309,000Source | — |
| Research and Development ExpenseUSD | — | — | 4,853,000Source | 3,003,000Source | 4,529,000Source | 947,000Source | 7,484,000Source | 1,326,000Source | 12,823,000Source | 4,170,000Source | 6,312,000Source | 8,742,000Source |
| Selling ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 307,913,000Source | — |
| Interest Expense (non-operating) | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | —Source | — | — | — | — | — | — | — | — | — |
Filing attachments
ea031154001ex99-1.htm · 8-K · 2026-11-09
Exhibit 99.1 NYSE: RFL November 2026 | Investor Presentation Forward - Looking Statements Some of the information in this presentation relates to future events or future business and financial performance. Such statements constitute forward - looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be only predictions and the actual events or results may differ from those discussed due to, among other things, the risks described in the…
Read attachment ↗ea030911501ex4-2.htm · 10-K · 2026-10-29
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Our authorized capital stock consists of (i) 35 million shares of Class A common stock, (ii) 200 million shares of Class B common stock, and (iii) 10 million shares of Preferred Stock. The following description of our classes of authorized stock does not purport to be complete and is subject to and qualified in its entirety by reference to our charter and bylaws, c…
Read attachment ↗ea030996101ex99-1.htm · 8-K · 2026-10-29
Exhibit 99.1 Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update NEWARK, NJ - October 29, 2026 (GLOBE NEWSWIRE) - Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the fourth quarter and full fiscal year 2026 ended July 31, 2026. Fiscal 2026 and Recent Corporate Highlights NDA submitted for remibetadex (Trappsol® Cyclo™). On October 28, 2026, Cyclo Therapeutics submitted a New Drug Application (NDA) to …
Read attachment ↗ea030996101ex99-2.htm · 8-K · 2026-10-29
Exhibit 99.2 Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C NDA supported by the Phase 3 TransportNPC™ study, data from earlier clinical studies, and an overall survival analysis versus external registry controls Remibetadex has received Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA; approval would make remibetadex eligible for a Rare Pediatric Disease Priori…
Read attachment ↗ea030712501ex99-1.htm · 8-K · 2026-09-30
Exhibit 99.1 Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC ™ Study of Trappsol ® Cyclo ™ in Niemann-Pick Disease Type C (NPC) Trappsol® Cyclo™ did not achieve statistical significance but demonstrated a directionally favorable treatment effect versus placebo on the primary endpoint of change in the 4-domain NPC Clinical Severity Scale (4DNPCSS) at Week 96 A prespecified analysis in patients receiving background miglustat and/or leucine therapy, representing a…
Read attachment ↗ea029744201ex99-1.htm · 8-K · 2026-07-08
EX-99.1 2 ea029744201ex99-1.htm INVESTOR PRESENTATION Exhibit 99.1 NYSE: RFL July 2026 | Investor Presentation Forward-Looking Statements Some of the information in this presentation relates to future events or future business and financial performance. Such statements constitute forward-looking information within the meaning of the Private Securities Litigation Act of 1995. Such statements can be only predictions and the actual events or results may differ from those discussed due to, amo…
Read attachment ↗